Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Cardioxyl Pharmaceuticals

Request full access

Develops and commercializes therapies for the treatment of cardiovascular disease

Chapel Hill, United StatesFounded 2005Biotech & Life Sciences

About Cardioxyl Pharmaceuticals

Cardioxyl Pharmaceuticals is a biotechnology company dedicated to developing innovative therapies for cardiovascular diseases, particularly heart failure and arrhythmias. The company operates in the biopharmaceutical market, targeting healthcare providers and patients who suffer from severe cardiovascular conditions. Cardioxyl's business model revolves around research and development (R&D) of novel drug candidates, which are then brought to market through clinical trials and regulatory approvals. Revenue is generated through the commercialization of these therapies, either directly or through partnerships with larger pharmaceutical companies. The company leverages its expertise in cardiovascular biology and medicinal chemistry to create treatments that address unmet medical needs, aiming to improve patient outcomes and quality of life.

Source: Dealroom company data

Cardioxyl Pharmaceuticals in the Chapel Hill ecosystem

Live from Dealroom

The Cardioxyl Pharmaceuticals office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Series B and later2 investors entered at this stage

Team profiled 11 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Patents

Estimated portfolio value
$33M

16 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

See Cardioxyl Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.